TMO logo

Thermo Fisher Scientific (TMO) EBITDA

annual EBITDA:

$11.54B+$456.00M(+4.12%)
December 31, 2024

Summary

  • As of today (April 12, 2025), TMO annual EBITDA is $11.54 billion, with the most recent change of +$456.00 million (+4.12%) on December 31, 2024.
  • During the last 3 years, TMO annual EBITDA has fallen by -$434.00 million (-3.63%).
  • TMO annual EBITDA is now -3.63% below its all-time high of $11.97 billion, reached on December 31, 2021.

Performance

TMO EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTMOincome statement metrics

quarterly EBITDA:

$3.00B+$162.00M(+5.71%)
December 31, 2024

Summary

  • As of today (April 12, 2025), TMO quarterly EBITDA is $3.00 billion, with the most recent change of +$162.00 million (+5.71%) on December 31, 2024.
  • Over the past year, TMO quarterly EBITDA has stayed the same.
  • TMO quarterly EBITDA is now -17.72% below its all-time high of $3.65 billion, reached on December 31, 2020.

Performance

TMO quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTMOincome statement metrics

TTM EBITDA:

$11.53B+$30.00M(+0.26%)
December 31, 2024

Summary

  • As of today (April 12, 2025), TMO TTM EBITDA is $11.53 billion, with the most recent change of +$30.00 million (+0.26%) on December 31, 2024.
  • Over the past year, TMO TTM EBITDA has stayed the same.
  • TMO TTM EBITDA is now -10.91% below its all-time high of $12.95 billion, reached on June 1, 2021.

Performance

TMO TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTMOincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

TMO EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+4.1%0.0%0.0%
3 y3 years-3.6%0.0%0.0%
5 y5 years+64.2%0.0%0.0%

TMO EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-3.6%+4.1%-15.2%+18.9%-4.5%+8.4%
5 y5-year-3.6%+64.2%-17.7%+96.3%-10.9%+69.3%
alltimeall time-3.6%>+9999.0%-17.7%+1005.8%-10.9%>+9999.0%

Thermo Fisher Scientific EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
$11.54B(+4.1%)
$3.00B(+5.7%)
$11.53B(+0.3%)
Sep 2024
-
$2.84B(-2.5%)
$11.50B(-1.2%)
Jun 2024
-
$2.91B(+4.4%)
$11.64B(+2.6%)
Mar 2024
-
$2.79B(-6.1%)
$11.35B(+2.4%)
Dec 2023
$11.08B(-7.2%)
$2.97B(-0.3%)
$11.08B(+0.7%)
Sep 2023
-
$2.98B(+14.0%)
$11.00B(+3.4%)
Jun 2023
-
$2.61B(+3.5%)
$10.64B(-2.7%)
Mar 2023
-
$2.52B(-12.9%)
$10.93B(-8.5%)
Dec 2022
$11.94B(-0.2%)
$2.89B(+10.8%)
$11.94B(+1.6%)
Sep 2022
-
$2.61B(-10.0%)
$11.75B(-2.7%)
Jun 2022
-
$2.90B(-17.9%)
$12.07B(+0.6%)
Mar 2022
-
$3.54B(+30.6%)
$12.01B(+0.3%)
Dec 2021
$11.97B(+18.4%)
$2.71B(-7.7%)
$11.97B(-7.3%)
Sep 2021
-
$2.93B(+3.6%)
$12.91B(-0.3%)
Jun 2021
-
$2.83B(-19.1%)
$12.95B(+7.2%)
Mar 2021
-
$3.50B(-4.0%)
$12.08B(+19.5%)
Dec 2020
$10.11B(+43.9%)
$3.65B(+22.7%)
$10.11B(+23.0%)
Sep 2020
-
$2.97B(+51.3%)
$8.22B(+20.7%)
Jun 2020
-
$1.96B(+28.5%)
$6.81B(-2.6%)
Mar 2020
-
$1.53B(-13.1%)
$6.99B(-0.5%)
Dec 2019
$7.03B(+13.4%)
$1.76B(+12.6%)
$7.03B(+0.2%)
Sep 2019
-
$1.56B(-27.2%)
$7.01B(+0.4%)
Jun 2019
-
$2.15B(+37.4%)
$6.98B(+9.4%)
Mar 2019
-
$1.56B(-10.4%)
$6.38B(+3.1%)
Dec 2018
$6.20B(+22.6%)
$1.74B(+13.5%)
$6.20B(+3.0%)
Sep 2018
-
$1.53B(-0.8%)
$6.01B(+6.8%)
Jun 2018
-
$1.55B(+12.8%)
$5.63B(+5.8%)
Mar 2018
-
$1.37B(-12.1%)
$5.32B(+5.3%)
Dec 2017
$5.05B(+18.9%)
$1.56B(+35.2%)
$5.05B(+6.4%)
Sep 2017
-
$1.15B(-6.7%)
$4.75B(+3.9%)
Jun 2017
-
$1.24B(+12.1%)
$4.57B(+3.7%)
Mar 2017
-
$1.10B(-12.2%)
$4.41B(+3.7%)
Dec 2016
$4.25B(+5.2%)
$1.26B(+29.0%)
$4.25B(+3.6%)
Sep 2016
-
$974.20M(-9.4%)
$4.10B(-0.5%)
Jun 2016
-
$1.07B(+13.7%)
$4.13B(+1.2%)
Mar 2016
-
$945.30M(-14.8%)
$4.08B(+1.0%)
Dec 2015
$4.04B(-5.0%)
$1.11B(+11.4%)
$4.04B(+0.7%)
Sep 2015
-
$996.40M(-2.9%)
$4.01B(-2.8%)
Jun 2015
-
$1.03B(+13.2%)
$4.13B(+5.8%)
Mar 2015
-
$906.70M(-16.2%)
$3.90B(-8.3%)
Dec 2014
$4.25B(+64.7%)
$1.08B(-2.7%)
$4.25B(+10.0%)
Sep 2014
-
$1.11B(+38.9%)
$3.87B(+14.1%)
Jun 2014
-
$800.40M(-36.4%)
$3.39B(+6.5%)
Mar 2014
-
$1.26B(+80.7%)
$3.18B(+23.2%)
Dec 2013
$2.58B(+3.5%)
$695.90M(+9.8%)
$2.58B(+1.2%)
Sep 2013
-
$633.70M(+6.8%)
$2.55B(+1.3%)
Jun 2013
-
$593.60M(-9.8%)
$2.52B(-0.9%)
Mar 2013
-
$658.30M(-0.9%)
$2.54B(+1.9%)
Dec 2012
$2.49B(+15.1%)
$664.10M(+10.3%)
$2.49B(+1.9%)
Sep 2012
-
$601.90M(-2.5%)
$2.45B(+2.4%)
Jun 2012
-
$617.40M(+1.0%)
$2.39B(+5.4%)
Mar 2012
-
$611.30M(-0.9%)
$2.27B(+4.6%)
Dec 2011
$2.17B(+13.0%)
$616.80M(+13.2%)
$2.17B(+6.5%)
Sep 2011
-
$544.70M(+10.1%)
$2.03B(+2.8%)
Jun 2011
-
$494.60M(-3.2%)
$1.98B(+1.2%)
Mar 2011
-
$511.10M(+5.6%)
$1.95B(+1.9%)
Dec 2010
$1.92B(+4.7%)
$483.80M(-1.0%)
$1.92B(-1.7%)
Sep 2010
-
$488.80M(+4.0%)
$1.95B(+0.9%)
Jun 2010
-
$470.20M(-1.1%)
$1.93B(+0.7%)
Mar 2010
-
$475.60M(-8.0%)
$1.92B(+4.8%)
Dec 2009
$1.83B(-11.6%)
$517.20M(+9.7%)
$1.83B(-0.3%)
Sep 2009
-
$471.60M(+3.4%)
$1.84B(-1.4%)
Jun 2009
-
$456.00M(+17.6%)
$1.87B(-3.5%)
Mar 2009
-
$387.70M(-25.9%)
$1.93B(-5.2%)
Dec 2008
$2.07B(+16.8%)
$523.50M(+5.1%)
$2.04B(+1.2%)
Sep 2008
-
$498.00M(-5.1%)
$2.02B(+2.4%)
Jun 2008
-
$524.60M(+6.2%)
$1.97B(+4.6%)
Mar 2008
-
$494.10M(-1.1%)
$1.88B(+6.1%)
Dec 2007
$1.77B(+235.6%)
$499.50M(+10.9%)
$1.77B(+21.7%)
Sep 2007
-
$450.40M(+2.7%)
$1.46B(+29.3%)
Jun 2007
-
$438.40M(+13.8%)
$1.13B(+40.1%)
Mar 2007
-
$385.10M(+109.8%)
$804.78M(+52.3%)
Dec 2006
$528.44M(+30.9%)
$183.54M(+52.9%)
$528.44M(+11.1%)
Sep 2006
-
$120.06M(+3.4%)
$475.79M(+2.1%)
Jun 2006
-
$116.07M(+6.7%)
$466.22M(+7.1%)
Mar 2006
-
$108.77M(-16.9%)
$435.36M(+7.9%)
Dec 2005
$403.66M(+26.3%)
$130.89M(+18.4%)
$403.57M(+10.8%)
Sep 2005
-
$110.50M(+29.7%)
$364.30M(+8.8%)
Jun 2005
-
$85.21M(+10.7%)
$334.74M(+2.8%)
Mar 2005
-
$76.97M(-16.0%)
$325.74M(+2.0%)
Dec 2004
$319.48M
$91.62M(+13.2%)
$319.48M(+2.2%)
Sep 2004
-
$80.94M(+6.2%)
$312.48M(+6.7%)
DateAnnualQuarterlyTTM
Jun 2004
-
$76.21M(+7.8%)
$292.89M(+2.4%)
Mar 2004
-
$70.72M(-16.4%)
$286.13M(+3.4%)
Dec 2003
$279.30M(+5.8%)
$84.62M(+37.9%)
$276.85M(+3.9%)
Sep 2003
-
$61.34M(-11.7%)
$266.40M(-1.6%)
Jun 2003
-
$69.45M(+13.1%)
$270.66M(+1.9%)
Mar 2003
-
$61.43M(-17.2%)
$265.71M(+0.7%)
Dec 2002
$263.93M(-0.6%)
$74.17M(+13.1%)
$263.93M(+3.8%)
Sep 2002
-
$65.61M(+1.7%)
$254.32M(+0.7%)
Jun 2002
-
$64.50M(+8.1%)
$252.46M(+0.8%)
Mar 2002
-
$59.65M(-7.6%)
$250.41M(-5.7%)
Dec 2001
$265.43M(-10.2%)
$64.56M(+1.3%)
$265.43M(-7.0%)
Sep 2001
-
$63.75M(+2.1%)
$285.52M(+1.6%)
Jun 2001
-
$62.45M(-16.4%)
$281.16M(-5.2%)
Mar 2001
-
$74.66M(-11.8%)
$296.58M(+0.3%)
Dec 2000
$295.65M(-18.4%)
$84.66M(+42.6%)
$295.65M(-4.7%)
Sep 2000
-
$59.39M(-23.7%)
$310.09M(-10.3%)
Jun 2000
-
$77.87M(+5.6%)
$345.74M(-7.6%)
Mar 2000
-
$73.73M(-25.6%)
$374.11M(-1.3%)
Dec 1999
$362.20M(+2.5%)
$99.10M(+4.3%)
$379.03M(+79.9%)
Sep 1999
-
$95.04M(-10.5%)
$210.73M(-18.3%)
Jun 1999
-
$106.24M(+35.1%)
$257.79M(-13.4%)
Mar 1999
-
$78.66M(-213.7%)
$297.56M(-14.9%)
Dec 1998
$353.40M(-4.9%)
-$69.20M(-148.7%)
$349.50M(-13.6%)
Sep 1998
-
$142.10M(-2.7%)
$404.50M(-2.5%)
Jun 1998
-
$146.00M(+11.8%)
$414.80M(+13.0%)
Mar 1998
-
$130.60M(-1019.7%)
$367.20M(+9.5%)
Dec 1997
$371.60M(-7.0%)
-$14.20M(-109.3%)
$335.40M(-23.2%)
Sep 1997
-
$152.40M(+54.9%)
$436.90M(+20.5%)
Jun 1997
-
$98.40M(-0.4%)
$362.60M(+11.1%)
Mar 1997
-
$98.80M(+13.2%)
$326.30M(+14.7%)
Dec 1996
$399.40M(+20.2%)
$87.30M(+11.8%)
$284.40M(+4.9%)
Sep 1996
-
$78.10M(+25.8%)
$271.00M(+3.7%)
Jun 1996
-
$62.10M(+9.1%)
$261.30M(+1.7%)
Mar 1996
-
$56.90M(-23.0%)
$256.90M(+3.8%)
Dec 1995
$332.30M(+37.3%)
$73.90M(+8.0%)
$247.40M(+9.0%)
Sep 1995
-
$68.40M(+18.5%)
$226.90M(+10.5%)
Jun 1995
-
$57.70M(+21.7%)
$205.40M(+7.8%)
Mar 1995
-
$47.40M(-11.2%)
$190.50M(+5.8%)
Dec 1994
$242.10M(+45.8%)
$53.40M(+13.9%)
$180.00M(+9.4%)
Sep 1994
-
$46.90M(+9.6%)
$164.60M(+4.6%)
Jun 1994
-
$42.80M(+16.0%)
$157.30M(+14.0%)
Mar 1994
-
$36.90M(-2.9%)
$138.00M(+0.1%)
Dec 1993
$166.00M(+70.3%)
$38.00M(-4.0%)
$137.80M(+16.4%)
Sep 1993
-
$39.60M(+68.5%)
$118.40M(+15.2%)
Jun 1993
-
$23.50M(-36.0%)
$102.80M(+6.7%)
Mar 1993
-
$36.70M(+97.3%)
$96.30M(+41.0%)
Dec 1992
$97.50M(+58.0%)
$18.60M(-22.5%)
$68.30M(+16.2%)
Sep 1992
-
$24.00M(+41.2%)
$58.80M(+33.9%)
Jun 1992
-
$17.00M(+95.4%)
$43.90M(+21.3%)
Mar 1992
-
$8.70M(-4.4%)
$36.20M(-1.4%)
Dec 1991
$61.70M(+13.4%)
$9.10M(0.0%)
$36.70M(-11.6%)
Sep 1991
-
$9.10M(-2.2%)
$41.50M(-9.6%)
Jun 1991
-
$9.30M(+1.1%)
$45.90M(+6.3%)
Mar 1991
-
$9.20M(-33.8%)
$43.20M(-0.2%)
Dec 1990
$54.40M(+78.4%)
$13.90M(+3.0%)
$43.30M(+19.0%)
Sep 1990
-
$13.50M(+104.5%)
$36.40M(+25.1%)
Jun 1990
-
$6.60M(-29.0%)
$29.10M(-83.2%)
Mar 1990
-
$9.30M(+32.9%)
$173.30M(-42.5%)
Dec 1989
$30.50M(+0.7%)
$7.00M(+12.9%)
$301.20M(-916.3%)
Sep 1989
-
$6.20M(-95.9%)
-$36.90M(-144.7%)
Jun 1989
-
$150.80M(+9.9%)
$82.50M(+55.4%)
Mar 1989
-
$137.20M(-141.4%)
$53.10M(+178.0%)
Dec 1988
$30.30M(+72.2%)
-$331.10M(-363.6%)
$19.10M(-63.8%)
Sep 1988
-
$125.60M(+3.5%)
$52.70M(+45.6%)
Jun 1988
-
$121.40M(+17.6%)
$36.20M(+251.5%)
Mar 1988
-
$103.20M(-134.7%)
$10.30M(+3333.3%)
Dec 1987
$17.60M(-15.0%)
-$297.50M(-372.7%)
$300.00K(-99.6%)
Sep 1987
-
$109.10M(+14.2%)
$67.00M(+55.5%)
Jun 1987
-
$95.50M(+2.5%)
$43.10M(+57.9%)
Mar 1987
-
$93.20M(-140.4%)
$27.30M(+120.2%)
Dec 1986
$20.70M(+63.0%)
-$230.80M(-370.9%)
$12.40M(-76.1%)
Sep 1986
-
$85.20M(+6.9%)
$51.80M(+74.4%)
Jun 1986
-
$79.70M(+1.8%)
$29.70M(+126.7%)
Mar 1986
-
$78.30M(-140.9%)
$13.10M(+172.9%)
Dec 1985
$12.70M(-33.9%)
-$191.40M(-403.3%)
$4.80M(-86.8%)
Sep 1985
-
$63.10M(0.0%)
$36.40M(+6.7%)
Jun 1985
-
$63.10M(-9.9%)
$34.10M(+23.1%)
Mar 1985
-
$70.00M(-143.8%)
$27.70M(+163.8%)
Dec 1984
$19.20M
-$159.80M(-362.8%)
$10.50M(-93.8%)
Sep 1984
-
$60.80M(+7.2%)
$170.30M(+55.5%)
Jun 1984
-
$56.70M(+7.4%)
$109.50M(+107.4%)
Mar 1984
-
$52.80M
$52.80M

FAQ

  • What is Thermo Fisher Scientific annual EBITDA?
  • What is the all time high annual EBITDA for Thermo Fisher Scientific?
  • What is Thermo Fisher Scientific annual EBITDA year-on-year change?
  • What is Thermo Fisher Scientific quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Thermo Fisher Scientific?
  • What is Thermo Fisher Scientific quarterly EBITDA year-on-year change?
  • What is Thermo Fisher Scientific TTM EBITDA?
  • What is the all time high TTM EBITDA for Thermo Fisher Scientific?
  • What is Thermo Fisher Scientific TTM EBITDA year-on-year change?

What is Thermo Fisher Scientific annual EBITDA?

The current annual EBITDA of TMO is $11.54B

What is the all time high annual EBITDA for Thermo Fisher Scientific?

Thermo Fisher Scientific all-time high annual EBITDA is $11.97B

What is Thermo Fisher Scientific annual EBITDA year-on-year change?

Over the past year, TMO annual EBITDA has changed by +$456.00M (+4.12%)

What is Thermo Fisher Scientific quarterly EBITDA?

The current quarterly EBITDA of TMO is $3.00B

What is the all time high quarterly EBITDA for Thermo Fisher Scientific?

Thermo Fisher Scientific all-time high quarterly EBITDA is $3.65B

What is Thermo Fisher Scientific quarterly EBITDA year-on-year change?

Over the past year, TMO quarterly EBITDA has changed by $0.00 (0.00%)

What is Thermo Fisher Scientific TTM EBITDA?

The current TTM EBITDA of TMO is $11.53B

What is the all time high TTM EBITDA for Thermo Fisher Scientific?

Thermo Fisher Scientific all-time high TTM EBITDA is $12.95B

What is Thermo Fisher Scientific TTM EBITDA year-on-year change?

Over the past year, TMO TTM EBITDA has changed by $0.00 (0.00%)
On this page